pmid,title,journal,year,drug,disease
30333571,Imatinib reduces non-alcoholic fatty liver disease in obese mice by targeting inflammatory and lipogenic pathways in macrophages and liver.,Scientific reports,2018,Imatinib,Non-alcoholic Fatty Liver Disease
27806304,Critical Roles of the Histone Methyltransferase MLL4/KMT2D in Murine Hepatic Steatosis Directed by ABL1 and PPARgamma2.,Cell reports,2016,Imatinib,Non-alcoholic Fatty Liver Disease
